SYNERGENE THERAPEUTICS INC

Company Information
Address 9812 FALLS RD 114
POTOMAC, MD, 20854-3963


Information

DUNS: 072898005

# of Employees: 3


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. HHSN261201400038C;SBIR TOPIC 326 DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS;PROJECT TITLE: CROSSING THE BBB AND TARGETING CSCS FOR GBM THERAPY;CONTRACT PERFORMANCE PERIOD 09

    Amount: $222,900.00

    Not Available

    SBIRPhase I2014Department of Health and Human Services
  2. TAS::75 0849::TAS- SYNERGENE, INC SBIR PHASE II OPTION PERIOD

    Amount: $498,331.00

    SBIR Phase II to develop a LYOPHILLIZED form of Optimized scL-gad-d complex

    SBIRPhase I2011Department of Health and Human Services
  3. SBIR TOPIC 266- A TARGETED NANOCOMPLEX FOR EARLY DETECTION OF LUNG CANCER

    Amount: $199,978.00

    SBIRPhase I2009Department of Health and Human Services
  4. TARGETED NANOCOMPLEXED IRON OXIDE FOR EARLY DETECTION WITH CONCURRENT HYPERTHERMI

    Amount: $199,735.00

    SBIRPhase I2009Department of Health and Human Services
  5. A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging

    Amount: $478,857.00

    DESCRIPTION (provided by applicant): The low rate of cure of pancreatic carcinoma is an important health problem. The American Cancer Society estimates that 32,000 Americans will be diagnosed with car ...

    STTRPhase I2006Department of Health and Human Services
  6. A Tumor-Specific Nanoimmunocomplex Markedly Improves MR Imaging

    Amount: $478,857.00

    DESCRIPTION (provided by applicant): The low rate of cure of pancreatic carcinoma is an important health problem. The American Cancer Society estimates that 32,000 Americans will be diagnosed with car ...

    SBIRPhase I2006Department of Health and Human Services
  7. A Dual Molecular/Tumor Targeting Therapy for PanCa

    Amount: $1,159,666.00

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa ...

    STTRPhase II2004Department of Health and Human Services
  8. Enhancement of Tumor-Targeted Transgene Expression

    Amount: $201,742.00

    DESCRIPTION (provided by applicant): In this application, the long-term goal is the development of an effective tumor-targeting lipoplex for systemic treatment of pancreatic cancer (PanCa), which has ...

    STTRPhase I2004Department of Health and Human Services
  9. Enhancement of Tumor-Targeted Transgene Expression

    Amount: $201,742.00

    DESCRIPTION (provided by applicant): In this application, the long-term goal is the development of an effective tumor-targeting lipoplex for systemic treatment of pancreatic cancer (PanCa), which has ...

    SBIRPhase I2004Department of Health and Human Services
  10. A Dual Molecular/Tumor Targeting Therapy for PanCa

    Amount: $1,159,670.00

    DESCRIPTION (provided by applicant): Approximately 30,000 people in the United States are diagnosed each year with pancreatic cancer (PanCa). Over 90% of these will die of the disease making PanCa ...

    SBIRPhase II2004Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government